In a bid to protect citizens against the MPOX virus, which was confirmed in the country on 31 July 2024, Kenya’s Ministry of Health has announced the upcoming rollout of MPOX vaccinations starting in December.

The government, through partnerships with the Centers for Disease Control (CDC) and various internal collaborations, is set to secure the necessary doses for nationwide distribution.

Mary Muthoni, the Principal Secretary for Public Health, highlighted that these efforts are part of Kenya’s commitment to safeguarding public health.

The collaboration with international agencies and local organizations aims to ensure that the vaccines reach the most vulnerable populations.

Mpox is an infectious disease that can cause a painful rash, enlarged lymph nodes, fever, headache, muscle ache, back pain and low energy.

This deadly virus has recently seen a resurgence in cases worldwide, prompting health authorities to take proactive measures.

Currently 14 countries in the African region are reporting cases since the start of 2024, with the Democratic Republic of the Congo accounting for around 90% of all cases.

As of October 14, 2024, Kenya had 13 confirmed cases of mpox. The cases were spread across the following counties:

Nakuru (2), Kajiado (2), Bungoma (2), Taita Taveta (1), Busia (1), Nairobi (1), Mombasa (1), Makueni (1), Kericho (1), and Kilifi (1).

With the vaccination program, Kenya joins a growing list of countries that have intensified their MPOX prevention efforts by implementing immunization as a key preventive measure.

The Ministry of Health is expected to announce further details on vaccine distribution logistics in the coming weeks.

As the December rollout nears, Kenyans are encouraged to stay informed on MPOX prevention and adhere to any public health guidelines provided.